ArriVent BioPharma, Inc. (AVBP) Earnings
NASDAQ·Healthcare·Biotechnology
$29.85
+0.03%
Mkt Cap $1.42B
EPS — Estimate vs Actual
Mkt Cap
$1.42B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53
NASDAQ·Healthcare·Biotechnology
$29.85
+0.03%
Mkt Cap $1.42B
Mkt Cap
$1.42B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53